Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

The neural plasticity of early-passage human bone marrow-derived mesenchymal stem cells and their modulation with chromatin-modifying agents.

Zhang Z, Alexanian AR.

J Tissue Eng Regen Med. 2014 May;8(5):407-13. doi: 10.1002/term.1535. Epub 2012 Jun 4.

PMID:
22674835
3.

Feline bone marrow-derived mesenchymal stem cells express several pluripotent and neural markers and easily turn into neural-like cells by manipulation with chromatin modifying agents and neural inducing factors.

Zhang Z, Maiman DJ, Kurpad SN, Crowe MJ, Alexanian AR.

Cell Reprogram. 2011 Oct;13(5):385-90. doi: 10.1089/cell.2011.0007. Epub 2011 Jun 30.

PMID:
21718099
4.

Comparative analysis of neuroectodermal differentiation capacity of human bone marrow stromal cells using various conversion protocols.

Hermann A, Liebau S, Gastl R, Fickert S, Habisch HJ, Fiedler J, Schwarz J, Brenner R, Storch A.

J Neurosci Res. 2006 Jun;83(8):1502-14.

PMID:
16612831
5.
6.

Isolation, characterization and neural differentiation potential of amnion derived mesenchymal stem cells.

Manochantr S, Tantrawatpan C, Kheolamai P, U-pratya Y, Supokawej A, Issaragrisil S.

J Med Assoc Thai. 2010 Dec;93 Suppl 7:S183-91.

PMID:
21294413
7.

Long-term serial passage and neuronal differentiation capability of human bone marrow mesenchymal stem cells.

Khoo ML, Shen B, Tao H, Ma DD.

Stem Cells Dev. 2008 Oct;17(5):883-96. doi: 10.1089/scd.2007.0185.

PMID:
18826370
8.

Human embryonic and fetal mesenchymal stem cells differentiate toward three different cardiac lineages in contrast to their adult counterparts.

Ramkisoensing AA, Pijnappels DA, Askar SF, Passier R, Swildens J, Goumans MJ, Schutte CI, de Vries AA, Scherjon S, Mummery CL, Schalij MJ, Atsma DE.

PLoS One. 2011;6(9):e24164. doi: 10.1371/journal.pone.0024164. Epub 2011 Sep 9.

9.

Quantitative approaches to detect donor and passage differences in adipogenic potential and clonogenicity in human bone marrow-derived mesenchymal stem cells.

Lo Surdo J, Bauer SR.

Tissue Eng Part C Methods. 2012 Nov;18(11):877-89. doi: 10.1089/ten.TEC.2011.0736. Epub 2012 Jun 25.

10.

Pluripotent gene expression in mesenchymal stem cells from human umbilical cord Wharton's jelly and their differentiation potential to neural-like cells.

Tantrawatpan C, Manochantr S, Kheolamai P, U-Pratya Y, Supokawej A, Issaragrisil S.

J Med Assoc Thai. 2013 Sep;96(9):1208-17.

PMID:
24163998
11.

Neuronal plasticity of human Wharton's jelly mesenchymal stromal cells to the dopaminergic cell type compared with human bone marrow mesenchymal stromal cells.

Datta I, Mishra S, Mohanty L, Pulikkot S, Joshi PG.

Cytotherapy. 2011 Sep;13(8):918-32. doi: 10.3109/14653249.2011.579957. Epub 2011 Jun 22.

PMID:
21696238
12.

Differentiation of mesenchymal stem cells derived from pancreatic islets and bone marrow into islet-like cell phenotype.

Zanini C, Bruno S, Mandili G, Baci D, Cerutti F, Cenacchi G, Izzi L, Camussi G, Forni M.

PLoS One. 2011;6(12):e28175. doi: 10.1371/journal.pone.0028175. Epub 2011 Dec 16.

13.

Comparison of bone marrow and adipose tissue-derived canine mesenchymal stem cells.

Takemitsu H, Zhao D, Yamamoto I, Harada Y, Michishita M, Arai T.

BMC Vet Res. 2012 Aug 31;8:150. doi: 10.1186/1746-6148-8-150.

14.

Dopaminergic-like cells from epigenetically reprogrammed mesenchymal stem cells.

Zhang Z, Alexanian AR.

J Cell Mol Med. 2012 Nov;16(11):2708-14. doi: 10.1111/j.1582-4934.2012.01591.x.

15.

Transplantation of neuronal-primed human bone marrow mesenchymal stem cells in hemiparkinsonian rodents.

Khoo ML, Tao H, Meedeniya AC, Mackay-Sim A, Ma DD.

PLoS One. 2011;6(5):e19025. doi: 10.1371/journal.pone.0019025. Epub 2011 May 23.

16.

HIF-1α is upregulated in human mesenchymal stem cells.

Palomäki S, Pietilä M, Laitinen S, Pesälä J, Sormunen R, Lehenkari P, Koivunen P.

Stem Cells. 2013 Sep;31(9):1902-9. doi: 10.1002/stem.1435.

17.

Human mesenchymal stem cells express neural genes, suggesting a neural predisposition.

Blondheim NR, Levy YS, Ben-Zur T, Burshtein A, Cherlow T, Kan I, Barzilai R, Bahat-Stromza M, Barhum Y, Bulvik S, Melamed E, Offen D.

Stem Cells Dev. 2006 Apr;15(2):141-64.

PMID:
16646662
18.

Epigenetic modulators promote mesenchymal stem cell phenotype switches.

Alexanian AR.

Int J Biochem Cell Biol. 2015 Jul;64:190-4. doi: 10.1016/j.biocel.2015.04.010. Epub 2015 Apr 29.

PMID:
25936755
19.

Mesenchymal stem cells and their subpopulation, pluripotent muse cells, in basic research and regenerative medicine.

Kuroda Y, Dezawa M.

Anat Rec (Hoboken). 2014 Jan;297(1):98-110. doi: 10.1002/ar.22798. Epub 2013 Dec 2. Review.

20.

Supplemental Content

Support Center